Literature DB >> 11893336

A Ca(2+) switch aligns the active site of calpain.

Tudor Moldoveanu1, Christopher M Hosfield, Daniel Lim, John S Elce, Zongchao Jia, Peter L Davies.   

Abstract

Ca(2+) signaling by calpains leads to controlled proteolysis during processes ranging from cytoskeleton remodeling in mammals to sex determination in nematodes. Deregulated Ca(2+) levels result in aberrant proteolysis by calpains, which contributes to tissue damage in heart and brain ischemias as well as neurodegeneration in Alzheimer's disease. Here we show that activation of the protease core of mu calpain requires cooperative binding of two Ca(2+) atoms at two non-EF-hand sites revealed in the 2.1 A crystal structure. Conservation of the Ca(2+) binding residues defines an ancestral general mechanism of activation for most calpain isoforms, including some that lack EF-hand domains. The protease region is not affected by the endogenous inhibitor, calpastatin, and may contribute to calpain-mediated pathologies when the core is released by autoproteolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893336     DOI: 10.1016/s0092-8674(02)00659-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  83 in total

1.  Activation of calpains mediates early lung neutrophilic inflammation in ventilator-induced lung injury.

Authors:  Dejie Liu; Zhibo Yan; Richard D Minshall; David E Schwartz; Yuguo Chen; Guochang Hu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-02       Impact factor: 5.464

2.  Keeping up with calcium: conference on calcium-binding proteins and calcium function in health and disease.

Authors:  Claude B Klee; Anthony R Means
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

Review 3.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

4.  Multiple interactions of the 'transducer' govern its function in calpain activation by Ca2+.

Authors:  Zoltán Bozóky; Anita Alexa; Peter Tompa; Peter Friedrich
Journal:  Biochem J       Date:  2005-06-15       Impact factor: 3.857

5.  Homodimerization of calpain 3 penta-EF-hand domain.

Authors:  Ravikiran Ravulapalli; Beatriz Garcia Diaz; Robert L Campbell; Peter L Davies
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

Review 6.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

7.  Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.

Authors:  Isaac T Schiefer; Subhasish Tapadar; Vladislav Litosh; Marton Siklos; Rob Scism; Gihani T Wijewickrama; Esala P Chandrasena; Vaishali Sinha; Ehsan Tavassoli; Michael Brunsteiner; Mauro Fa'; Ottavio Arancio; Pavel Petukhov; Gregory R J Thatcher
Journal:  J Med Chem       Date:  2013-07-22       Impact factor: 7.446

8.  Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of mu-calpain.

Authors:  Latha Satish; Harry C Blair; Angela Glading; Alan Wells
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease.

Authors:  Takahide Kaji; Barry Boland; Tatjana Odrljin; Panaiyur Mohan; Balapal S Basavarajappa; Corrinne Peterhoff; Anne Cataldo; Anna Rudnicki; Niranjana Amin; Bing Sheng Li; Harish C Pant; Basalingappa L Hungund; Ottavio Arancio; Ralph A Nixon
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

10.  Calcium-Activated Calpain Specifically Cleaves Glutamate Receptor IIA But Not IIB at the Drosophila Neuromuscular Junction.

Authors:  Elsayed Metwally; Guoli Zhao; Wenhua Li; Qifu Wang; Yong Q Zhang
Journal:  J Neurosci       Date:  2019-01-31       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.